These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2475346)

  • 21. [An experimental study on liver hyperthermia using intraperitoneal hyperthermic perfusion (IPHP)].
    Kitagawa T; Ku Y; Saitoh Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2295-7. PubMed ID: 7944463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.
    Rossi CR; Vecchiato A; Foletto M; Nitti D; Ninfo V; Fornasiero A; Sotti G; Tregnaghi A; Melanotte P; Lise M
    Cancer; 1994 Apr; 73(8):2140-6. PubMed ID: 8156518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
    Haier J; Hohenberger P; Beck K; Schlag PM
    Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment.
    Vujaskovic Z; Poulson JM; Gaskin AA; Thrall DE; Page RL; Charles HC; MacFall JR; Brizel DM; Meyer RE; Prescott DM; Samulski TV; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):179-85. PubMed ID: 10656391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
    Wydra D; Emerich J
    Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs].
    Di Filippo F; Patrizi V; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Filippo S; Vespa A
    Suppl Tumori; 2005; 4(3):S126-7. PubMed ID: 16437946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusion.
    Grabellus F; Podleska LE; Bjerlestam S; Sheu SY; Lendemans S; Schmid KW; Taeger G
    Int J Hyperthermia; 2011; 27(1):33-41. PubMed ID: 21073296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients.
    Stein U; Jürchott K; Schläfke M; Hohenberger P
    J Clin Oncol; 2002 Aug; 20(15):3282-92. PubMed ID: 12149303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfusion and thermal field during hyperthermia. Experimental measurements and modelling in recurrent breast cancer.
    Guiot C; Madon E; Allegro D; Piantà PG; Baiotto B; Gabriele P
    Phys Med Biol; 1998 Oct; 43(10):2831-43. PubMed ID: 9814521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
    Didolkar MS; Fitzpatrick JL; Jackson AJ; Johnston GS
    Cancer; 1986 May; 57(10):1961-6. PubMed ID: 3955502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calculating regional tissue volume for hyperthermic isolated limb perfusion: Four methods compared.
    Cecchin D; Negri A; Frigo AC; Bui F; Zucchetta P; Bodanza V; Gregianin M; Campana LG; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2016 Dec; 42(12):1898-1905. PubMed ID: 27005884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
    Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
    Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hyperthermic perfusion in the treatment of tumors of the extremities.
    Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R
    Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyperthermic regional perfusion in malignant melanoma of an extremity].
    Andersson AP; Drzewiecki KT
    Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
    Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
    Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the method of hyperthermic chemotherapy by regional isolated perfusion for tumors of lower extremities].
    Xu SW; Chen F; Chao YH
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):310-3. PubMed ID: 7805565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion analyses in advanced breast carcinoma during hyperthermia.
    Lagendijk JJ; Hofman P; Schipper J
    Int J Hyperthermia; 1988; 4(5):479-95. PubMed ID: 3292667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis.
    Cho HK; Lush RM; Bartlett DL; Alexander HR; Wu PC; Libutti SK; Lee KB; Venzon DJ; Bauer KS; Reed E; Figg WD
    J Clin Pharmacol; 1999 Apr; 39(4):394-401. PubMed ID: 10197298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intractible cutaneous non-Hodgkin's lymphoma of the lower limb. Complete remission after sequential regional isolated hyperthermic perfusion and perfusion with 1-phenylalanine-mustard (melphalan, L-Pam).
    Jansen RF; van Geel BN; van der Zee J; Hagenbeek A; Levendag PC
    Cancer; 1989 Jul; 64(2):392-5. PubMed ID: 2736485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.